What is the appropriate workup for a young woman with generalized lymphadenopathy, night sweats, neutrophilic leukocytosis, and elevated ferritin?

Workup for Multiple Site Lymph Node Enlargement in Young Female with Night Sweats, Neutrophilic Leukocytosis, and High Ferritin

This presentation demands immediate excisional lymph node biopsy to rule out lymphoma (particularly Hodgkin lymphoma), while simultaneously evaluating for hemophagocytic lymphohistiocytosis (HLH), Adult-Onset Still's Disease (AOSD), and severe infection.

Immediate Priority: Lymphoma Exclusion

The constellation of generalized lymphadenopathy, night sweats (a classic B symptom), and systemic inflammation in a young woman mandates lymphoma workup as the first priority. An excisional lymph node biopsy is required—fine-needle aspiration is inadequate for initial diagnosis 1, 2. A core needle biopsy may be acceptable only if excisional biopsy is not feasible, but a nondiagnostic sample must be followed by excisional biopsy 1.

Essential Diagnostic Studies:

Tissue Diagnosis:

• Excisional lymph node biopsy with immunostaining for CD3, CD15, CD20, CD30, CD45, CD79a, and PAX5 2
• Request flow cytometry and molecular studies 1
• Store additional tissue for future research with consent 1

Staging Imaging (if lymphoma confirmed):

• PET-CT scan (skull base to midthigh) is the standard for staging FDG-avid lymphomas 1, 2
• PET-CT eliminates the need for routine bone marrow biopsy if negative or showing homogenous uptake 2
• Diagnostic contrast-enhanced CT (neck, chest, abdomen, pelvis) at minimum for areas abnormal on PET 2

Critical Parallel Evaluation: Hyperferritinemia Syndrome

The combination of extremely elevated ferritin with fever represents a medical emergency requiring simultaneous evaluation for four life-threatening conditions 3:

Calculate H-Score Immediately

The H-score must be calculated urgently to assess HLH probability 4, 5, 6. An H-score ≥169 reaches 82-95% sensitivity and 60-94% specificity for HLH 7. Key features distinguishing conditions:

• HLH/MAS: Cytopenias (particularly thrombocytopenia, anemia), organomegaly (hepatosplenomegaly), hypertriglyceridemia, hypofibrinogenemia, hemophagocytosis on bone marrow 4, 5, 6
• AOSD: Neutrophilic leukocytosis (not cytopenia), quotidian fever pattern, salmon-colored evanescent rash, polyarthralgia, ferritin often >5,000 μg/L 3, 5
• Septic shock: Positive cultures, clear infectious source, response to antibiotics 3

Specific Laboratory Workup:

Complete blood count with differential - Look for:

• Neutrophilic leukocytosis → favors AOSD or infection over HLH 5
• Cytopenias (≥2 lineages) → strongly suggests HLH 6

Inflammatory markers:

• ESR, CRP 2, 8
• Ferritin level (if >10,000 μg/L, HLH becomes more likely, though this threshold is more validated in pediatrics) 7
• Transferrin saturation (TSAT) to guide ferritin interpretation 7

HLH-specific tests:

• Triglycerides, fibrinogen 6
• Soluble IL-2 receptor (sCD25) if available
• NK cell activity and soluble CD163 6

AOSD-specific:

• Glycosylated ferritin (if available; <20% supports AOSD) 3
• Apply Yamaguchi criteria 5

Infectious workup:

• Blood cultures, tuberculosis testing 8
• HIV, hepatitis B and C serology 2
• EBV, CMV serologies (common HLH triggers) 6

Autoimmune screening:

• ANA, RF, anti-CCP (for AOSD and to exclude lupus/rheumatoid arthritis) 8

Algorithmic Approach Based on Initial Results:

If H-score ≥169 + cytopenias + organomegaly:

• Presume HLH → Bone marrow biopsy for hemophagocytosis 6
• Start immunosuppression (IV steroids, consider anakinra if inadequate response) 6
• ICU monitoring may be required 6
• Continue lymphoma workup as HLH can be lymphoma-driven 6

If neutrophilic leukocytosis + ferritin >5,000 μg/L + quotidian fever + rash + polyarthralgia:

• Presume AOSD 5
• Exclude infection and malignancy first 3
• Lymph node biopsy may show Kikuchi-Fujimoto-like changes (diagnostic pitfall) 5
• Treatment: steroids, methotrexate, or IL-1 inhibitors 3, 5

If lymph node biopsy shows lymphoma:

• Complete staging per Lugano classification 1
• Assess cardiac function (ejection fraction) before anthracycline therapy 2
• Document B symptoms: fever >38.3°C, drenching night sweats, weight loss >10% in 6 months 2

Critical Pitfalls to Avoid:

1. Do not start corticosteroids before tissue diagnosis - they can mask lymphoma histology 8
2. Do not rely on fine-needle aspiration alone - inadequate for lymphoma diagnosis 1, 2
3. Do not delay biopsy for empiric antibiotics - if infection suspected, obtain cultures first but proceed with biopsy within days if no improvement 8, 3
4. Do not assume ferritin >10,000 μg/L = HLH in adults - this threshold is less specific in adults than pediatrics 7
5. Do not miss the low H-score - if H-score is low (e.g., <100) despite high ferritin, consider AOSD or infection over HLH 4, 5

Timeline Considerations:

Lymphadenopathy persisting >4 weeks with systemic symptoms mandates imaging and laboratory studies 8. Given the acute presentation with B symptoms and leukocytosis, this workup should be completed within days, not weeks. PET-CT should be obtained no longer than 1 month before starting therapy if lymphoma is diagnosed 2.